Advertisement
Person › Details
Anthony Dyer (Novacyt S.A. (Euronext Growh: ALNOV, AIM: NCYT))
Dyer, Anthony (Novacyt 201409– Finance Director before part time Group Financial Controller)
Organisation | Novacyt S.A. (Euronext Growh: ALNOV, AIM: NCYT) | |
Group | Novacyt (Group) | |
Product | diagnostics (medical/biological) | |
Product 2 | cell analysis technology | |
Record changed: 2021-01-07 |
Advertisement
More documents for Anthony Dyer
- [1] Novacyt S.A.. (1/5/21). "Press Release: Executive Management and Proposed Board Changes". Paris & Camberley....
- [2] Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge....
- [3] Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top